The Centers for Disease Control and Prevention announced that it has awarded $216 million over five years to 90 community-based organizations (CBOs) nationwide to deliver effective HIV prevention strategies to those at risk.
House and Senate Appropriation Committees passed FY16 funding bills that maintain funding for specific domestic HIV and hepatitis programs while they drastically cut many other programs that are critical to preventing and treating HIV and hepatitis.
CytoDyn Inc. announced that recent research data has expanded the potential clinical indications for PRO 140, now in Phase 3 for the treatment of HIV, to include certain inflammatory diseases, autoimmunity, transplantation and cancer.
Larry Kramer polarized the gay community even before the AIDS epidemic; but his anger at the government's inactivity inspired a movement. EDGE speaks to doc filmmaker Jean Carlomusto on Kramer & the making of her HBO film "Larry Kramer in Love and Anger."
French-based Biosantech Company reported that the company's HIV vaccine candidate is not toxic to 48 HIV-positive patients enrolled in a double-blind study that is taking place in France.
Findings published in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs shows extreme promise in stopping the spread of HIV.
Eric Brus looks at Gov. Cuomo's Blueprint to End AIDS, plus the updated LGBT Health Guide from Fenway, and June 27 HIV Testing Day.
New UCLA research offers further evidence that cocaine use disrupts the immune system, making one more likely to become infected with HIV.
A group of UK schoolchildren revolutionized safe sex when they created a new condom that changes color when it comes into contact with a sexually transmitted infection.
In recognition of National HIV Testing Day on June 27, The AIDS Institute reminds individuals to get tested so that they can learn their HIV status.